THE ULTIMATE GUIDE TO 4F-MDMB K2 INFUSED PAPER

(b) If the executive commissioner establishes a application below this subchapter, the commissioner shall publish a report not later than January one of every odd-numbered year around the healthcare effectiveness of the use of tetrahydrocannabinols as well as their derivatives and any other health-related findings from the research application.(e)